Dr. Reder is a serial pharmaceutical and diagnostic development entrepreneur who has deep expertise in pharmaceutical commercialization, regulatory strategy, and public and private equity financing. In 2008, he founded Celdara Medical as a way to bridge academic innovation and patient benefit. Of note, Celdara Medical brought a diagnostic service to market in 2010, a cellular therapy to the clinic in 2014, and spun-out and sold OnCyte, LLC in 2015 for >$500M in cash, stock, milestones and sponsored research, plus tiered royalties on sales. Previously, Jake led new business platforms and projects, external innovation, and knowledge management initiatives at Cabot Corporation. He started Cabot’s Printed Electronics Business and Optical Composites Platform, and was a member of Cabot’s Research Council, Technology Board, and Nanotechnology EHS Council. Jake joined Cabot’s New Business Development team from PolyTechnos Venture-Partners, a Munich-based venture capital firm where he built deal flow, conducted due diligence, and advised on early stage technology investments.
Dr. Reder provides pharmaceutical development, regulatory, and third-party investment expertise to the advisory team.